Drug Profile

Factor X - Bio Products Laboratory

Alternative Names: Coagadex

Latest Information Update: 07 Jan 2026

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Bio Products Laboratory
Developer Bio Products Laboratory; Kedrion Biopharma
Class Antihaemorrhagics; Blood coagulation factors; Coagulants
Mechanism of Action Blood coagulation factor replacements

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

Yes - Factor X deficiency
New Molecular Entity No

Highest Development Phases

Marketed Factor X deficiency

Most Recent Events

29 Jul 2025 US FDA grants ODD to factor X for the treatment of acquired Factor X Deficiency
29 Jul 2025 Phase-III clinical trials in Factor X deficiency (IV) (NCT06963216)
29 Jul 2025 US FDA provides "Study may proceed letter" for the initiation of phase III trial in Factor X deficiency

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com